These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 11122147)
21. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation. Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960 [TBL] [Abstract][Full Text] [Related]
22. Leukemia inhibitory factor in long-term adherent layer cultures: increased levels of bioactive protein in leukemia and modulation by IL-4, IL-1 beta, and TNF-alpha. Wetzler M; Estrov Z; Talpaz M; Kim KJ; Alphonso M; Srinivasan R; Kurzrock R Cancer Res; 1994 Apr; 54(7):1837-42. PubMed ID: 8137298 [TBL] [Abstract][Full Text] [Related]
23. Expression and function of c-kit receptor in bone marrow mononuclear cells of patients with myelodysplastic syndromes. Shao Z; Zhang H; Chen G; Wang L; Li K; Zhang Y; Li L; Sun J Chin Med J (Engl); 2001 May; 114(5):481-5. PubMed ID: 11780408 [TBL] [Abstract][Full Text] [Related]
24. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia. Wetzler M; Kurzrock R; Estrov Z; Estey E; Talpaz M Leuk Res; 1995 Jan; 19(1):23-34. PubMed ID: 7837815 [TBL] [Abstract][Full Text] [Related]
25. Effect of chemotherapy for acute myelogenous leukemia on hematopoietic and fibroblast marrow progenitors. Carlo-Stella C; Tabilio A; Regazzi E; Garau D; La Tagliata R; Trasarti S; Andrizzi C; Vignetti M; Meloni G Bone Marrow Transplant; 1997 Sep; 20(6):465-71. PubMed ID: 9313879 [TBL] [Abstract][Full Text] [Related]
26. Clonal growth of haemopoietic progenitor cells from myelodysplastic marrow in response to recombinant haemopoietins. Baines P; Bowen D; Jacobs A Leuk Res; 1990; 14(3):247-53. PubMed ID: 1690828 [TBL] [Abstract][Full Text] [Related]
27. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model. Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615 [TBL] [Abstract][Full Text] [Related]
28. Bone marrow stromal culture from patients with myelodysplastic syndromes and patients at different stages of acute nonlymphocytic leukaemia. Elstner E; Wächter M; Ihle R Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):167-74. PubMed ID: 2472321 [TBL] [Abstract][Full Text] [Related]
29. In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF). Faulhaber M; Wörmann B; Ganser A; Verbeek W Ann Hematol; 2002 Dec; 81(12):695-700. PubMed ID: 12483365 [TBL] [Abstract][Full Text] [Related]
31. Neutrophil-specific reduction in the expression of granulocyte--macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes. Shikama Y; Shichishima T; Ohto H; Jubinsky PT; Maruyama Y Br J Haematol; 2000 Dec; 111(3):863-72. PubMed ID: 11122148 [TBL] [Abstract][Full Text] [Related]
32. Fibronectin increases both non-adherent cells and CFU-GM while collagen increases adherent cells in human normal long-term bone marrow cultures. Hassan HT; Sadovinkova EYu ; Drize NJ; Zander AR; Neth R Haematologia (Budap); 1997; 28(2):77-84. PubMed ID: 9283907 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs. Hong DS; Graham T; Ewel C; Storb R; Deeg HJ Exp Hematol; 1995 Jul; 23(7):639-44. PubMed ID: 7601256 [TBL] [Abstract][Full Text] [Related]
34. Characterization of stroma-adherent colony-forming cells: a clonogenic assay for early hemopoietic cells? Tucker D; Bol S; Kannourakis G Exp Hematol; 1993 Mar; 21(3):469-74. PubMed ID: 8440345 [TBL] [Abstract][Full Text] [Related]
35. Erythropoietin-independent erythroid colony formation by bone marrow progenitors exposed to interleukin-11 and interleukin-8. Corre-Buscail I; Pineau D; Boissinot M; Hermouet S Exp Hematol; 2005 Nov; 33(11):1299-308. PubMed ID: 16263414 [TBL] [Abstract][Full Text] [Related]
36. Peripheral blood granulocyte-macrophage progenitors in patients with the myelodysplastic syndromes. Tennant GB; Jacobs A; Bailey-Wood R Exp Hematol; 1986 Dec; 14(11):1063-8. PubMed ID: 3780888 [TBL] [Abstract][Full Text] [Related]
37. Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes. Stasi R; Pagano A; Terzoli E; Amadori S Br J Haematol; 1999 Apr; 105(1):141-8. PubMed ID: 10233377 [TBL] [Abstract][Full Text] [Related]
38. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia. Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985 [TBL] [Abstract][Full Text] [Related]
39. Long-term marrow culture of cells from patients with acute myelogenous leukemia. Selection in favor of normal phenotypes in some but not all cases. Coulombel L; Eaves C; Kalousek D; Gupta C; Eaves A J Clin Invest; 1985 Mar; 75(3):961-9. PubMed ID: 3856572 [TBL] [Abstract][Full Text] [Related]
40. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome. Flores-Figueroa E; Gutiérrez-Espíndola G; Montesinos JJ; Arana-Trejo RM; Mayani H Leuk Res; 2002 Jul; 26(7):677-86. PubMed ID: 12008086 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]